Search Within

Subhiksha Nandakumar

  1. "2021"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Medicine (5)
  2. Genitourinary Oncology Service (5)
  3. Sloan Kettering Institute Postdocs (5)
  4. Solid Tumor Oncology Division (5)
  5. Computational Oncology Service (2)
  6. Epidemiology and Biostatistics (2)

More Groups

People
  1. Goutam Chakraborty (4)
  2. Lina Jehane (4)
  3. Philip Kantoff (4)
  4. Rahim Hirani (4)
  5. Ying Mazzu (4)
  6. Daniel Danila (3)

More People

Years
  1. 2021 (5)
Publications
  1. Cancer Research (3)
  2. Clinical Cancer Research (1)
  3. Journal of Clinical Oncology (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Integration of genomic and clinical data from 25,000 patients identifies molecular determinants of metastatic potential and organotropisms
    Meeting Abstract

    Nguyen, B.; Fong, C.; DiNatale, R.; Luthra, A.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Rajanna, A.; Solit, D. B.; Berger, M. F.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save